DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 41.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,304,100 shares of the medical instruments supplier’s stock after purchasing an additional 672,200 shares during the quarter. Edmond DE Rothschild Holding S.A. owned approximately 1.16% of DENTSPLY SIRONA worth $43,732,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB increased its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares in the last quarter. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 1,568 shares during the last quarter. Finally, Quarry LP lifted its holdings in DENTSPLY SIRONA by 455.0% in the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock valued at $82,000 after purchasing an additional 2,489 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on XRAY shares. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. UBS Group dropped their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Mizuho lowered their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research note on Thursday, March 13th. Finally, Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $23.33.

Check Out Our Latest Analysis on XRAY

Insider Activity

In other news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $14.93 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market cap of $2.97 billion, a P/E ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98. The firm’s 50 day moving average price is $17.62 and its 200-day moving average price is $20.16. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.22.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.29%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.